Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert

Founder and Director of the Sbarro Health Research Organization (SHRO), Antonio Giordano, M.D., Ph.D., is uniquely qualified to comment on the current COVID-19 outbreak caused by the novel coronavirus known as SARS-CoV-2. A former physician turned research scientist, Giordano collaborates with scientists working in both the United States and Italy through projects with SHRO, Temple University, and the University of Siena, Italy, as well as other institutions around the world.
Sbarro Health Research Organization (SHRO)

The following op-ed first appeared in La Voce di New York, an English- and Italian-language publication, and is translated and excerpted below. 

By Antonio Giordano, M.D., Ph.D. 

Newswise — The disease caused by the new coronavirus has a name:  "COVID-19," where "CO" stands for crown, "VI" for virus, "D" for disease and "19" indicates the year in which it occurred. The most common symptoms include fever, cough, and breathing difficulties. Although symptoms are very similar to those of a seasonal flu, the viruses are different; therefore, in suspected cases of Coronavirus, laboratory tests are required to confirm the diagnosis.

A swab is made to collect mucus and saliva from the patient's throat and identify the people who have contracted the pathogen and are therefore able to spread it. The search for antibodies is necessary to understand if you have already come into contact with the virus, and it is useful to conduct epidemiological studies to know, in retrospect, how many people have become infected.

The incubation period represents the period of time that passes between the infection and the development of clinical symptoms. It is currently estimated that it varies between 2 and 11 days, up to a maximum of 14. We must try to curb alarmism, but be aware of what is going on, and understand that the number of subjects found positive in Italy and in Europe will increase. This is inevitable for two reasons; the first is that we now know that SARS-CoV-2, the virus that causes COVID-19, is very infectious and the mode of contagion occurs when those who already have the infection do not show obvious symptoms. Second, identifying the subjects who have come into contact with those who are already positive will have the inevitable consequence of finding others.

What can be said for sure is that these infections are more easily conveyed in closed rooms and by relatively close contacts less than 6 feet away. And, the incidence of death is higher among those over age sixty-five and subjects affected by other chronic pathologies, due to weaker immune systems and related vulnerabilities.

Misinformation, fake news and psychosis on coronavirus go hand in hand: among the many dubious theories prevelant on the internet is the suggestion that the virus was conceived as a biological weapon by China, or other versions that claim it was created in  laboratories in the U.S.

Recent numbers indicate approximately 90,000 cases have been confirmed for the new coronavirus (SARS-CoV-2) worldwide since the beginning of the epidemic, with approximately 3,000 deaths recorded. For comparison, as reported on the site of the World Health Organization (WHO), globally, every year, the flu virus affects between 5 and 15% of the adult population (i.e. from 350 million to 1 billion people), an incidence that rises to 20-30% in children.

Between 3 and 5 million cases of influenza reported annually evolve into complications that cause death in about 10%, (about 500 thousand people in the world), especially among the population groups at risk (children under 5 years, the elderly, and people with chronic diseases). In Italy, at the end of the 2018-2019 flu season, there had been 8,104,000 cases, and based on the most updated data, from 14 October 2019 to 16 February 2020 the number of flu-like cases was 5,632,000; with a daily average of 217 deaths, data published on the InfluNet website  (the national epidemiological and virological surveillance system of influenza, coordinated by the Ministry of Health with the collaboration of the ISS).

At the moment, coronavirus, according to data from China, has an estimated mortality of around 3-4%. Mers, the "Middle Eastern" coronavirus epidemic, recorded 2,494 cases with 858 deaths, with a lethality rate of 34.4%. The best known SARS epidemic, over two years, recorded 8,096 cases with 774 deaths, with a lethality rate of 9.6%. The Ebola virus, whose ongoing epidemic in the Democratic Republic of the Congo is still an international WHO public health emergency, has an estimated lethality rate of around 50%.

The statement that the new coronavirus epidemic is a global health emergency aims to raise awareness and improve international coordination; the concern, in fact, is also that which may spread the virus to countries with weak health systems.

Knowing the situation will allow us to develop increasingly effective measures. Without a doubt, each of us can, with our responsible behavior, act as a barrier to the spread of the virus.

 

About the Sbarro Health Research Organization

The Sbarro Health Research Organization (SHRO) is non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. To learn more about the SHRO please visit www.shro.org

 




Filters close

Showing results

110 of 2528
10-Jul-2020 9:00 AM EDT
Long-term strategies to control COVID-19 pandemic must treat health and economy as equally important, argue researchers
University of Cambridge

Strategies for the safe reopening of low and middle-income countries (LMICs) from months of strict social distancing in response to the ongoing COVID-19 pandemic must recognise that preserving people’s health is as important as reviving the economy, argue an international team of researchers.

Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.


Showing results

110 of 2528

close
0.9585